Various pharmaceutical products for rescEU Medical -project

Finnish Institute for Health and Welfare

Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for various pharmaceutical products to the rescEU Medical -project. The Scope of procurement is described in more detail in the Annex 1. The procurement is divided in ten (10) lots. Each Article constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01) LOT 2: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02) LOT 3: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14) LOT 4: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05) LOT 5: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05) LOT 6: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14) LOT 7: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02) LOT 8: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01) LOT 9: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05) LOT 10: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02) The tender shall consist of one (1) Article for each tendered lot. The minimum requirements for the Article is described in the Annex 1.1. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the Articles is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of December 2028 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract draft Annex 3 Security annex Annex 4 JYSE 2025 SUPPLIES Annex 5 Confidentiality commitment Annex 6 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract draft and the Call for tenders. The numbering of the Annexes to the Contract draft is based on the order of precedence applied in the Contract.

Määräaika

Deadline 2026-12-21

Kuka? Mitä? Missä?
Hankintojen historia
Päivämäärä Asiakirja
2026-11-13 hankintailmoitus
hankintailmoitus (2026-11-13)
Kohde
Hankinnan laajuus
Otsikko: Various pharmaceutical products for rescEU Medical -project
Viitenumero: THL/3594/2026
Lyhyt kuvaus:
Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for various pharmaceutical products to the rescEU Medical -project. The Scope of procurement is described in more detail in the Annex 1. The procurement is divided in ten (10) lots. Each Article constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01) LOT 2: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02) LOT 3: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14) LOT 4: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05) LOT 5: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05) LOT 6: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14) LOT 7: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02) LOT 8: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01) LOT 9: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05) LOT 10: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02) The tender shall consist of one (1) Article for each tendered lot. The minimum requirements for the Article is described in the Annex 1.1. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the Articles is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of December 2028 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract draft Annex 3 Security annex Annex 4 JYSE 2025 SUPPLIES Annex 5 Confidentiality commitment Annex 6 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract draft and the Call for tenders. The numbering of the Annexes to the Contract draft is based on the order of precedence applied in the Contract.
Näytä lisää
Sopimustyyppi: Tavarat
Tuotteet/palvelut: Farmaseuttiset tuotteet 📦
Suorituspaikkaa koskevat rajoitukset: Missä tahansa tietyn maan alueella
Tietoa eristä
Tämä sopimus on jaettu osiin ✅
Yhdelle tarjoajalle myönnettävien erien enimmäismäärä: 10
Tarjouksia voidaan jättää enintään yhtä erää varten: 10

1️⃣
Sisäinen tunniste: 1-0
Otsikko: LOT 1: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01)
Tämä hankinta soveltuu myös pienille ja keskisuurille yrityksille (pk-yrityksille) ✅
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01) - Active pharmaceutical ingredient: Electrolytes (ringer's solution) - Container size: 1000 ml - Pharmaceutical form: intravenous infusion - ATC code: B05BB01 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Lisätietoja:
The availability for the Annex 6 is restricted to security classification level IV (TL IV). THL will send the Annex 6 to a representative of the tenderer via encrypted email after THL has received a scanned version of the signed Confidentiality commitment (Annex 5). The signature of the Confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/3594/2026 / Various pharmaceutical products for rescEU Medical -project". The message shall contain name of the tenderer and email address to which the Annex 6 is to be sent.
Näytä lisää
Tuotteet/palvelut: Veren korvikkeet ja perfuusioliuokset 📦
Maa: Suomi 🇫🇮
Kesto: 24 kuukautta
Kesto
Aloituspäivä: 2027-01-11 📅
Tietoa vaihtoehdoista
Vaihtoehdot ✅
Vaihtoehtojen kuvaus:
In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of December 2028 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.
Näytä lisää
Myöntämisperusteet
Hinta ✅
Hinta (painotus): 65
Laatukriteeri (nimi): Quality 1: Registered shelf life of the Article
Laatukriteeri (painotus): 15
Laatukriteeri (nimi): Quality 2: Delivery time to the customer’s warehouse
Laatukriteeri (painotus): 10
Laatukriteeri (nimi): Quality 3: Transportation temperature and excursions
Laatukriteeri (painotus): 3
Laatukriteeri (nimi): Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging
Laatukriteeri (painotus): 7
Otsikko
Erän tunnistenumero: LOT-0001

2️⃣
Sisäinen tunniste: 2-1
Otsikko: LOT 2: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02) - Active pharmaceutical ingredient: Electrolytes with carbohydrates - Strength: 50 mg/ml - Container size: 500 ml - Pharmaceutical form: solution for infusion - ATC code: B05BB02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Otsikko
Erän tunnistenumero: LOT-0002

3️⃣
Sisäinen tunniste: 3-2
Otsikko: LOT 3: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14) - Active pharmaceutical ingredient: Esketamine - Strength: 25 mg/ml - Container size: 2 ml - Pharmaceutical form: solution for injection/infusion, vial/ampoule - ATC code: N01AX14 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Tuotteet/palvelut: Anestesia-aineet 📦
Otsikko
Erän tunnistenumero: LOT-0003

4️⃣
Sisäinen tunniste: 4-3
Otsikko: LOT 4: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05) - Active pharmaceutical ingredient: Oxycodone - Strength: 10 mg/ml - Container size: 1 ml - Pharmaceutical form: solution for injection, vial/ampoule - ATC code: N02AA05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Tuotteet/palvelut: Analgeetit 📦
Otsikko
Erän tunnistenumero: LOT-0004

5️⃣
Sisäinen tunniste: 5-4
Otsikko: LOT 5: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05) - Active pharmaceutical ingredient: Oxycodone - Strength: 10 mg/ml - Container size: 10 ml - Pharmaceutical form: solution for injection, vial/ampoule - ATC code: N02AA05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Otsikko
Erän tunnistenumero: LOT-0005

6️⃣
Sisäinen tunniste: 6-5
Otsikko: LOT 6: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14) - Active pharmaceutical ingredient: Levetiracetam - Strength: 100 mg/ml - Container size: 5 ml - Pharmaceutical form: concentrate for solution for infusion, vial - ATC code: N03AX14 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Tuotteet/palvelut: Epilepsialääkkeet 📦
Otsikko
Erän tunnistenumero: LOT-0006

7️⃣
Sisäinen tunniste: 7-6
Otsikko: LOT 7: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02) - Active pharmaceutical ingredient: Cefuroxime - Strength: 1500 mg - Pharmaceutical form: powder for solution for injection, vial - ATC code: J01DC02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Tuotteet/palvelut: Systeemiset bakteerilääkkeet 📦
Otsikko
Erän tunnistenumero: LOT-0007

8️⃣
Sisäinen tunniste: 8-7
Otsikko: LOT 8: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01) - Active pharmaceutical ingredient: Vancomycin - Strength: 1000 mg - Pharmaceutical form: powder for solution for injection, vial - ATC code: J01XA01 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Otsikko
Erän tunnistenumero: LOT-0008

9️⃣
Sisäinen tunniste: 9-8
Otsikko: LOT 9: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05) - Active pharmaceutical ingredient: Enoxaparin - Strength: 100 mg/ml - Container size: 1 ml - Pharmaceutical form: sub-cutaneous, pre-filled syringe - ATC code: B01AB05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Tuotteet/palvelut: Antitromboottiset lääkeaineet 📦
Otsikko
Erän tunnistenumero: LOT-0009

1️⃣0️⃣
Sisäinen tunniste: 10-9
Otsikko: LOT 10: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02)
Hankinnan kuvaus:
The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02) - Active pharmaceutical ingredient: Tranexamic acid - Strength: 100 mg/ml - Container size: 10 ml - Pharmaceutical form: intra muscular/intravenous, vial/ampoule - ATC code: B02AA02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).
Näytä lisää
Tuotteet/palvelut: Hemostaatit 📦
Otsikko
Erän tunnistenumero: LOT-0010

Menettely
Toimenpiteen tyyppi
Avoin menettely ✅
Oikeusperusta: Direktiivi 2014/24/EU
Menettelyn tärkeimmät piirteet:
Tenders must be submitted electronically via the Cloudia Supplier Portal. It is the responsibility of the tenderer to submit the tender by the deadline. No compensation will be paid for submitting a tender. Requirements concerning tenderers and the Article, as well as eventual reports and explanations required in the tender, are described in this Call for tenders. All the attachments mentioned in the Call for tenders should be sent with the tender. The tender must be submitted in writing, in English. Also, the attachments and all related material or correspondence must be in English. The process steps are: 1. Opening the tenders. 2. Inspecting the suitability of tenderers according to the ESPD form. 3. Inspecting that tenders meet the requirements set in the Call for tenders. 4. Comparison of tenders. 5. Making and announcing the Procurement decision. 6. Verifying the information given by the awarded tenderer on the ESPD form. 7. Background check by asking the winning tenderer to submit criminal record exctracts. 8. Drafting the Contract. The Contract is only valid after a written Contract is signed. The Contract can be signed no earlier than 14 days from the time the tenderers has been informed, or is considered to have been informed, of the Procurement decision and its grounds (= stand-still period).
Näytä lisää
Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2026-12-21 10:00:00 📅
Tarjousten avaamista koskevat ehdot: 2026-12-21 10:30:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6 kuukautta
Tarjouspyynnön ehdot
Tarjoaja voi jättää useamman kuin yhden tarjouksen
Tarjousten avaamisen päivämäärä: 2026-12-21 10:30:00 📅
Sähköinen laskutus: Sallittu
Sähköistä maksua käytetään ✅
Lisätietojen pyytämisen määräaika: 2026-12-09 10:00:00 📅
Myöntämisperusteet
Painotustyyppi: Painotus (pisteinä, tarkka)
Tarjouspyynnön ehdot
Salassapitosopimus on pakollinen ✅

Hankintaviranomainen
Nimi ja osoitteet
Nimi: Finnish Institute for Health and Welfare
Kansallinen rekisterinumero: 2229500-6
Postiosoite: P. O. BOX 30
Postinumero: 00271
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa 🏙️
Maa: Suomi 🇫🇮
Yhteyspiste: Procurement services / Keskitetty hankintatoimi
Sähköposti: kilpailutus@thl.fi 📧
Puhelin: +358 295246000 📞
URL: https://thl.fi/en/web/thlfi-en 🌏
Hankintaviranomaisen tyyppi
Ministeriö tai muu kansallinen tai liittovaltiotason viranomainen
Päätoimi
Terveys
Viestintä
Osallistumisen URL-osoite: https://tarjouspalvelu.fi/thl?id=637182&tpk=490ff13b-24f0-4cd2-bd62-4fdc29eaba9d 🌏
EU:n rahoituksen tunniste: rescEU-MED-CBRN-FI
Lisätietoa EU-rahoituksesta: rescEU - Medical Stockpiling in Finland
EU:n rahoitusohjelma: Unionin pelastuspalvelumekanismi (rescEU) (2021/2027)
Perustelut tiettyjen hankinta-asiakirjojen saatavuuden rajoittamiselle: Erityisen arkaluonteisten tietojen suojaaminen
Hankinta-asiakirjoihin pääsyä on rajoitettu
Tarjouksen/hakemuksen jättäminen sähköisesti: Pakollinen

Täydentävät tiedot
Lisätietoja
The availability for the Annex 6 is restricted to security classification level IV (TL IV). THL will send the Annex 6 to a representative of the tenderer via encrypted email after THL has received a scanned version of the signed Confidentiality commitment (Annex 5). The signature of the Confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/3594/2026 / Various pharmaceutical products for rescEU Medical -project". The message shall contain name of the tenderer and email address to which the Annex 6 is to be sent.
Näytä lisää
Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa 🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi 📧
Puhelin: +358 295643300 📞
URL: http://www.oikeus.fi/markkinaoikeus 🌏
Palvelu, josta voi saada tietoja uudelleentarkastelumenettelystä
Sama kuin: Arvostelurunko
Uudelleentarkastelumenettely
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista):
Time limit for submitting a request for rectification: A party must request rectification of procurement within 14 days of receiving notice of the decision of the contracting entity (together with instructions for appeal) or of some other resolution made in the procurement procedure. The claim must be submitted by the date when the time limit for submitting a request expires, within office hours. The day of notice is not included in the calculation of the time limit. If the last day for submitting a request is a bank holiday, Independence Day (6 December), the First of May, Christmas Eve, Midsummer Eve or a Saturday, the request for rectification may be submitted on the first weekday following that day, within office hours. Time limit for seeking review: An appeal must be filed in writing within 14 days of the date on which the party received notice of the procurement decision together with instructions for appeal. The day of notice is not included in the calculation of the time limit. The Market Court must receive the appeal by the date when the time limit for submitting the appeal expires, within its opening hours.
Näytä lisää
Tietoa sähköisistä työnkuluista
Sähköinen laskutus hyväksytään
Lähde: OJS 2026/S 222-795969 (2026-11-13)